SCHEMBL13638663

SCHEMBL13638663

C=C1CC(Nc2nccc(-c3ccc(CC4CC4C(C)(C)O)s3)n2)CC(C)(C)N1

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 6/20 0.34
CHUK O15111 6/20 0.34
IKBKG Q9Y6K9 6/20 0.34
MAPK9 P45984 1/20 0.30
CDK1 P06493 1/20 0.30
CDK4 P11802 1/20 0.30
CCNB1 P14635 1/20 0.30
CCNA2 P20248 1/20 0.30
CCND1 P24385 1/20 0.30
CDK2 P24941 1/20 0.30
CCNA1 P78396 1/20 0.30
PIK3C3 Q8NEB9 2/20 0.30
PIK3CD O00329 1/20 0.30
PIK3CA P42336 1/20 0.30
PIK3CG P48736 1/20 0.30
PI4KB Q9UBF8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4482916 0.88 IKBKB (0.36) IKBKBCHUKIKBKGCDK1CDK4
SCHEMBL13638458 0.87 IKBKB (0.36) IKBKBCHUKIKBKGMAPK9CDK1
SCHEMBL13638500 0.85 IKBKB (0.33) IKBKBCHUKIKBKGMAPK9CDK1
SCHEMBL13638557 0.85 IKBKB (0.45) IKBKBCHUKIKBKGMAPK9CDK1
SCHEMBL13638579 0.85 SRC (0.35) IKBKBCHUKIKBKGMAPK9CDK1
SCHEMBL13638418 0.84 IKBKB (0.34) IKBKBCHUKIKBKGCDK1CDK4
SCHEMBL13638665 0.84 IKBKB (0.39) IKBKBCHUKIKBKGMAPK9CDK1
SCHEMBL13638288 0.84 CDK1 (0.32) MAPK9CDK1CDK4CCNB1CCNA2
SCHEMBL13638667 0.84 CDK1 (0.32) MAPK9CDK1CDK4CCNB1CCNA2
SCHEMBL13638429 0.82 IKBKB (0.34) IKBKBCHUKIKBKGMAPK9CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed